Adamas pharmaceuticals inc (ADMS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets
Cash and cash equivalents

45,541

65,774

71,973

62,737

58,936

56,605

56,766

40,604

50,942

91,316

22,121

33,618

20,918

23,735

9,776

109,272

98,406

33,104

37,118

37,927

29,228

61,446

137,526

144,607

79,799

85,612

Available-for-sale securities

69,741

66,833

78,267

105,910

131,699

154,265

154,701

162,380

147,588

82,126

101,605

94,725

91,155

89,917

92,409

46,854

64,876

73,691

66,330

86,544

85,263

60,912

-

-

-

-

Accounts receivable, net

5,747

5,770

5,536

6,411

7,498

5,511

5,276

3,412

1,613

367

3

34

1,689

794

769

860

461

1,284

936

361

485

524

120

218

251

129

Inventory

5,381

5,267

5,120

5,653

5,202

5,121

5,176

3,768

2,455

1,704

425

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

6,974

6,676

6,382

6,296

6,465

6,871

4,385

4,815

3,492

3,662

2,806

1,814

1,474

2,541

7,433

6,335

5,837

5,108

1,070

1,586

540

645

1,284

956

542

267

Total current assets

133,384

150,320

167,278

187,007

209,800

228,373

226,304

214,979

206,090

179,175

126,960

130,191

115,236

116,987

110,387

163,321

169,580

113,187

105,454

126,418

115,516

123,527

138,930

145,781

80,592

86,008

Property and equipment, net

2,213

2,449

2,705

2,971

3,294

3,652

3,972

2,809

3,296

3,132

3,110

3,107

3,138

3,156

3,078

3,375

2,916

2,353

2,141

1,963

1,294

1,228

443

336

254

199

Operating lease right-of-use assets

7,704

8,048

8,215

7,592

7,368

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities, non-current

-

-

-

-

-

-

21,730

53,293

88,125

2,991

7,004

16,586

10,086

22,292

43,725

1,906

5,924

13,165

29,145

18,645

30,495

36,364

-

-

-

-

Prepaid expenses and other non-current assets

1,010

1,341

2,241

2,661

2,764

2,789

5,114

5,165

-

878

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

877

-

38

38

38

38

38

38

38

38

38

38

38

70

-

70

-

9

Deferred offering costs and Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

-

1,949

-

Total assets

144,311

162,158

180,439

200,231

223,226

234,814

257,120

276,246

298,388

186,176

137,112

149,922

128,498

142,473

157,228

168,640

178,458

128,743

136,778

147,064

147,343

161,189

139,443

146,187

82,795

86,216

Liabilities and stockholders’ deficit
Current liabilities
Accounts payable

3,672

6,932

6,775

6,351

10,242

6,570

8,982

7,823

8,132

3,878

5,380

4,385

3,018

3,589

5,956

4,720

3,509

3,052

2,856

3,859

3,806

3,685

3,033

3,284

1,985

2,097

Accrued liabilities

15,044

16,117

16,007

16,258

16,609

15,530

15,359

13,124

12,353

12,385

9,539

6,396

4,937

5,867

6,306

7,843

6,884

8,457

7,828

5,846

4,161

8,595

3,517

2,556

2,430

2,119

Current portion of long-term debt

3,232

2,041

1,739

1,585

1,527

1,664

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

1,830

1,858

1,837

1,523

1,452

512

957

735

435

344

292

268

306

287

301

267

266

298

272

298

138

265

146

151

4

2

Total current liabilities

23,778

26,948

26,358

25,717

29,830

24,276

25,298

21,682

20,920

16,607

15,211

11,049

8,261

9,743

12,563

12,830

10,659

11,807

10,956

10,003

8,105

12,545

6,696

5,991

4,419

4,218

Long-term debt

126,065

125,674

124,078

121,943

119,661

117,457

115,353

111,283

107,105

102,647

35,408

33,768

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of operating lease liabilities

7,823

8,272

8,607

8,367

8,366

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,020

6,232

Other non-current liabilities

2,498

2,157

1,639

1,501

1,453

3,196

2,073

721

760

796

615

1,201

-

547

-

-

-

749

-

-

-

1,570

-

8

-

12

Non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

492

-

600

649

699

-

1,832

1,940

1,685

-

-

-

-

-

Deferred revenue and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

-

Total liabilities

160,164

163,051

160,682

157,528

159,310

144,929

142,724

133,686

128,785

120,050

51,234

46,018

8,753

10,290

13,163

13,479

11,358

12,556

12,788

11,943

9,790

14,115

6,696

5,999

8,450

10,462

Commitments and Contingencies (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ deficit
Preferred stock, $0.001 par value — 5,000,000 shares authorized, and zero shares issued and outstanding at December 31, 2019 and December 31, 2018

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Preferred stock, $0.001 par value — 5,000,000 shares authorized, and zero shares issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

-

0

0

0

-

0

0

0

-

0

0

-

-

-

-

-

0

-

-

23,013

19,149

Common stock, $0.001 par value — 100,000,000 shares authorized, 28,158,205 and 27,964,778 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

33

33

32

32

32

32

32

32

32

28

27

27

27

27

27

27

26

23

23

23

22

22

22

21

14

14

Additional paid-in capital

448,573

446,942

444,465

439,795

436,274

432,815

428,612

423,616

416,604

277,964

268,305

263,042

258,121

254,558

251,351

247,957

243,042

178,473

175,406

171,746

160,135

157,581

152,805

150,690

78,270

77,163

Accumulated other comprehensive gain

73

16

69

103

-34

-264

-433

-425

-363

-167

-112

-183

-166

-193

-64

32

11

-158

22

-46

-53

-180

-

-

-

-

Accumulated deficit

-464,532

-447,884

-424,809

-397,227

-372,356

-342,698

-313,815

-280,663

-246,670

-211,699

-182,342

-158,982

-138,237

-122,209

-107,249

-92,855

-75,979

-62,151

-51,461

-36,602

-22,551

-10,349

-20,080

-10,523

-26,952

-20,572

Total stockholders’ deficit

-15,853

-893

19,757

42,703

63,916

89,885

114,396

142,560

169,603

66,126

85,878

103,904

119,745

132,183

144,065

155,161

167,100

116,187

123,990

135,121

137,553

147,074

132,747

140,188

51,332

56,605

Total liabilities and stockholders’ deficit

144,311

162,158

180,439

200,231

223,226

234,814

257,120

276,246

298,388

186,176

137,112

149,922

128,498

142,473

157,228

168,640

178,458

128,743

136,778

147,064

147,343

161,189

139,443

146,187

82,795

86,216